| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Reference |
| Mycoplasma synoviae |
- |
- |
0.006 － 1 |
599 |
| Mycoplasma synoviae (1975-1989) |
- |
- |
0.031 － 1 |
606 |
| Mycoplasma synoviae (1990-2000) |
- |
- |
0.006 － 0.5 |
606 |
| Mycoplasma synoviae (WVU 1853) |
- |
- |
≤0.03 － ? |
595 |
| Pasteurella multocida |
4 |
- |
4 － 16 |
608 |
| Pasteurella multocida |
4.8 |
1240 |
1.2 － 1240 |
608 |
| Pasteurella multocida |
32 |
32 |
16 － 32 |
760 |
| Salmonella |
8 |
- |
4 － 32 |
760 |
| Salmonella enterica |
256 |
512 |
128 － 512 |
760 |
| Staphylococcus aureus (8325-4) |
- |
- |
1 － ? |
613 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.5 － ? |
772 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.5 － ? |
1167 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
1 － ? |
601 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
1 － ? |
615 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
2 － ? |
593 |
| Staphylococcus aureus (ATCC 33591) |
- |
- |
0.5 － ? |
615 |
| Staphylococcus aureus (erythromycin-resistant) |
0.5 |
1 |
≤0.25 － 1 |
592 |
| Staphylococcus aureus (erythromycin-susceptible + mupirocin-susceptible + oxacillin-susceptible) |
0.5 |
1 |
≤0.25 － 2 |
592 |
| Staphylococcus aureus (IV20204009 + France) |
- |
- |
32 － ? |
601 |
| Staphylococcus aureus (IV20205004 + France) |
- |
- |
16 － ? |
601 |
| Staphylococcus aureus (IV20217008 + Portugal) |
- |
- |
32 － ? |
601 |
| Staphylococcus aureus (IV20217033 + Portugal) |
- |
- |
>64 － ? |
601 |
| Staphylococcus aureus (IV20222009 + Ireland) |
- |
- |
16 － ? |
601 |
| Staphylococcus aureus (JSB20013) |
- |
- |
0.125 － ? |
748 |
| Staphylococcus aureus (mupirocin-resistant) |
0.5 |
1 |
≤0.25 － 1 |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
0.5 |
1 |
≤0.25 － 2 |
592 |
| Staphylococcus aureus (RN1024) |
- |
- |
16 － ? |
601 |
| Staphylococcus aureus (RN1024-tms) |
- |
- |
0.5 － ? |
601 |